XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect Period Of Adoption Adjustment [Member]
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2018 $ 4,569.7 $ (2.4) $ 184.0 $ 3,541.9 $ 1,558.6 $ (2.2) $ (785.6) $ (0.2) $ 70.8
Beginning balance (in shares) at Dec. 31, 2018     184.0            
Net earnings 715.8       668.8       47.0
Net purchase of subsidiary shares from noncontrolling interests (15.1)               (15.1)
Dividends paid to noncontrolling interests (43.0)               (43.0)
Net change in pension asset/liability, net of taxes 4.7           4.7    
Foreign currency translation 44.5           44.2   0.3
Change in fair value of derivative instruments, net of taxes (22.7)           (22.7)    
Compensation expense related to stock option plan grants 14.0     14.0          
Common stock issued in: purchase transactions 168.0   $ 1.9 166.1          
Common stock issued in: purchase transactions (in shares)     1.9            
Stock option plans 73.7   $ 1.8 71.9          
Stock option plans (in shares)     1.8            
Employee stock purchase plan 27.5   $ 0.3 27.2          
Employee stock purchase plan (in shares)     0.3            
Deferred compensation and restricted stock 4.7   $ 0.1 4.6          
Deferred compensation and restricted (in shares)     0.1            
Cash dividends declared on common stock (323.9)       (323.9)        
Ending balance at Dec. 31, 2019 5,215.5   $ 188.1 3,825.7 1,901.3   (759.6)   60.0
Ending balance (in shares) at Dec. 31, 2019     188.1            
Net earnings 858.1       818.8       39.3
Net purchase of subsidiary shares from noncontrolling interests (6.4)               (6.4)
Dividends paid to noncontrolling interests (46.8)               (46.8)
Net change in pension asset/liability, net of taxes 0.4           0.4    
Foreign currency translation 184.1           183.7   0.4
Change in fair value of derivative instruments, net of taxes (68.1)           (68.1)    
Compensation expense related to stock option plan grants 13.6     13.6          
Common stock issued in: purchase transactions 309.1   $ 3.0 306.1          
Common stock issued in: purchase transactions (in shares)     3.0            
Stock option plans $ 77.7   $ 1.8 75.9          
Stock option plans (in shares) 1.8   1.8            
Employee stock purchase plan $ 34.2   $ 0.5 33.7          
Employee stock purchase plan (in shares)     0.5            
Deferred compensation and restricted stock 9.7   $ 0.3 9.4          
Deferred compensation and restricted (in shares)     0.3            
Cash dividends declared on common stock (348.4)       (348.4)        
Ending balance at Dec. 31, 2020 $ 6,232.7   $ 193.7 4,264.4 2,371.7   (643.6)   46.5
Ending balance (in shares) at Dec. 31, 2020 193.7   193.7            
Net earnings $ 955.0       906.8       48.2
Net purchase of subsidiary shares from noncontrolling interests (6.0)               (6.0)
Dividends paid to noncontrolling interests (38.3)               (38.3)
Net change in pension asset/liability, net of taxes 19.0           19.0    
Foreign currency translation (121.0)           (122.3)   1.3
Change in fair value of derivative instruments, net of taxes 20.8           20.8    
Compensation expense related to stock option plan grants 17.5     17.5          
Common stock issued in: purchase transactions 251.3   $ 1.7 249.6          
Common stock issued in: purchase transactions (in shares)     1.7            
Stock option plans $ 67.6   $ 1.4 66.2          
Stock option plans (in shares) 1.4   1.4            
Employee stock purchase plan $ 41.2   $ 0.4 40.8          
Employee stock purchase plan (in shares)     0.4            
Shares issued to benefit plans 71.4   $ 0.6 70.8          
Shares issued to benefit plans (in shares)     0.6            
Stock issuance from public offering 1,437.9   $ 10.3 1,427.6          
Stock issuance from public offering (in shares)     10.3            
Other compensation expense 0.3     0.3          
Deferred compensation and restricted stock 6.9   $ 0.4 6.5          
Deferred compensation and restricted (in shares)     0.4            
Cash dividends declared on common stock (396.2)       (396.2)        
Ending balance at Dec. 31, 2021 $ 8,560.1   $ 208.5 $ 6,143.7 $ 2,882.3   $ (726.1)   $ 51.7
Ending balance (in shares) at Dec. 31, 2021 208.5   208.5